BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Cidara Therapeutics, Inc. (CDTX)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Cidara Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-14
10:18 am
Purchase		 2023-12-31 13G Cidara Therapeutics, Inc.
CDTX		 BIOTECHNOLOGY VALUE FUND L P 463,776
9.990%		 120,720increase
(+35.19%)		 Filing
2021-12-16
5:16 pm
Purchase		 2021-12-14 13G Cidara Therapeutics, Inc.
CDTX		 BIOTECHNOLOGY VALUE FUND L P 343,056
10.300%		 119,982increase
(+53.79%)		 Filing
2021-02-12
4:06 pm
Purchase		 2020-12-31 13G Cidara Therapeutics, Inc.
CDTX		 BIOTECHNOLOGY VALUE FUND L P 223,075
9.990%		 54,637increase
(+32.44%)		 Filing